跳至主要内容
临床试验/NL-OMON26257
NL-OMON26257尚未招募不适用

GLUCOZOND: the impact of dietary intake on continous glucose levels in healthy people

Strategic Program RIVM0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • BMI 18.5-30 kg/m2
  • - 18-65 years old
  • - Subjectively health

排除标准

  • - Illiteracy
  • - Not being able to give informed consent
  • - Do not have a doctor
  • - Use of medicines that can influence glucose levels: such as beta-adrenergic receptor antagonists ('betablockers')
  • - Pregnancy, breastfeeding, women who are actively trying to conceive
  • - Acute and / or chronic disease that prevents the test subject from adhering to the research protocol.
  • - Metabolic and / or hormonal disorders, such as diabetes mellitus
  • - Swallowing problems, delayed stomach emptying
  • - Allergies for the standard snack, such as gluten intolerance
  • - Practicing extreme sports (for example, marathon, triathlon)
  • - Practicing a very physically demanding job such as in construction.
  • - Known allergic skin reaction during the use of continuous glucose monitoring or patches in general

研究者

发起方
Strategic Program RIVM

相似试验